Published by Benjamin Chiou on 13th October 2025
(Sharecast News) - IP Group said it is "encouraged" by the results of a recent clinical trial of a Metsara obesity drug, which could result in future sustainable royalties if approved by regulators.
URL: http://www.digitallook.com/dl/news/story/35416752/...